Home Your basket
• Facial nerve monitoring i...
   Price 10.50 €
• Cholesteatoma behind a no...
   Price 10.50 €
• Correlation between laryn...
   Price 10.50 €
• The neurotologic evaluati...
   Price 10.50 €
• Vertigo: progress and pra...
   Price 8.50 €
• Therapeutic choices for c...
   Price 8.50 €
• Notes on voice and speech...
   Price 8.50 €
• Migraine, neurone and ves...
   Price 5.50 €
• Vocal forcing and posture...
   Price 10.50 €
• Middle ear adenoma / carc...
   Price 8.50 €
• Cervico facial lymphangio...
   Price 10.50 €
• Treatment and rehabilitat...
   Price 10.50 €
• Lateral fixation of the v...
   Price 8.50 €
• Otogenic pneumocephalus: ...
   Price 5.50 €
• Audiological comparison b...
   Price 14.00 €
• Paediatric endoscopic sin...
   Price 10.50 €
• Merkel cell carcinoma of ...
   Price 8.50 €
• Metastatic melanoma to th...
   Price 5.50 €
• A new look on septoplasti...
   Price 10.50 €
• Clinical signs and correl...
   Price 10.50 €
• Benign paroxysmal vertigo...
   Price 8.50 €
• Congenital bilateral choa...
   Price 5.50 €
• Early ENT manifestations ...
   Price 10.50 €
• Contribution of clinical ...
   Price 14.00 €
• How I do it: Salivary duc...
   Price 8.50 €
• A simple assessment of qu...
   Price 10.50 €
• Which face lift for which...
   Price 14.00 €
• Pathophysiology of choles...
   Price 10.50 €
• Clinical Practice Guideli...
   Price 12.00 €
• Efficacy of voice therapy...
   Price 10.50 €
• Develop­ment of an osteos...
   Price 8.50 €
• Role of positron emission...
   Price 15.00 €
• Prosody and reading: Temp...
   Price 12.00 €
• Nasal cutaneous cryptococ...
   Price 5.50 €

Total Order 332.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2004 o

MISCELLANEOUS

Early ENT manifestations of HIV infection / AIDS. An analysis of 76 cases observed in Africa


Authors : A. Ndjolo, R. Njock, N. M. Ngowe, M. M. B. Ebogo, M. Toukam, S. Nko’o, G. Bengono (Yaounde)

Ref. : Rev Laryngol Otol Rhinol. 2004;125,1:39-43.

Article published in french
Downloadable PDF document english



Summary : Objective: The aim of this work is to describe the ENT clinical manifestations by which HIV positive patients inaugurate their AIDS-illness and to classify these manifestations in respect to the biological state of the infection. Material and method: It was a multicenter, prospective study carried out in the ENT services of Yaounde (Cameroon), between the period of september 2000 and june 2002. Included in this study were HIV patients who started their AIDS with an ENT illness. The stage of evolution of the HIV infection was evaluated using the CD4 and CD8 T lymphocyte counts. This was carried out using the Flux cytometric technique of Fascount/Becton. Results: We thereafter recruited 76 patients. The incidence rate of ENT early manifestations in HIV positive patients was 11.5%. Pharyngeal and oral candidosis represented the most observed manifestation (30.60%), followed by peripheral facial paralysis (11.13%) and rhino-sinusitis (10.58%). Parotid gland hypertrophy represented 8.23% of the affections. Persistant cervical lymphadenopathy was observed in 7.05% of cases. Kaposi sarcoma and cervical lymph node tuberculosis represented each 3.53% of cases of the sample. The correlation of lymphocytic count and initial ENT manifestations showed that these manifestations were observed in all the biological states of the HIV/AIDS infection. Conclusion: the above mentioned ENT manifestations in the patient should motivate the request of the HIV screening tests.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE